|
|
 |
|
Viewing report
|
|
|
|
The Pharmaceutical Market: Cuba
Espicom Business Intelligence Ltd, Feb 2008, Pages: 96
Cuba is one of the world's last unreconstructed communist countries. Under Dr Fidel Castro’s Presidency, Cuba has attempted none of the economic reforms implemented in Eastern Europe or even China. With his brother Raul taking over the Presidency in February 2008 and with Fidel still acting as consultant to major decisions, it appears that political changes will be slow, if they happen. Despite this, the country has a reputation for the quality of its health services and health indicators, and has an impressive pharmaceutical/biotechnology research sector. This reputation is deserved in part, but conceals an ageing healthcare system in dire need of restructuring and modernising, none of which can be achieved without greatly increased funding.
During the Cold War, Cuba was a major Soviet ally, and the market remained largely closed to the West. During the 1990s, however, many countries in the West established links with Cuba. The USA, virtually alone, maintains its embargo against Cuba. This is starting to hurt US healthcare firms, as companies based in Asia, Canada and Western Europe have the high-tech market to themselves. The international healthcare industry is taking an increasing interest in Cuba, which in turn has made efforts to integrate into the global marketplace in an attempt to attract new funding for its healthcare system.
Since its realignment under the consortium QUIMEFA in 2001, domestic pharmaceutical production has kept growing, with increasing biotechnology export opportunities not only in developing countries but also in Europe and other developed countries. Cuba maintains a list of essential medicines (CBM – Cuadro Basico de Medicamentos), which contained 828 medicines in 2007, of which 525 are domestically produced. There is no commercial advertising in Cuba, instead advertising has an educational purpose. Cuba affords some level of pharmaceutical patent protection, although less than international norms. Since 2001, FARMACUBA has acted as importer, exporter and distributor for QUIMEFA.
Customers who bought this item also bought
The Pharmaceutical Market: Ukraine
The Pharmaceutical Market: Australia
Otsuka Pharmaceutical Co Deals Briefing
Chinese Pharmaceutical Industry
Indian Pharmaceutical Industry: The Changing Prescription
The Pharmaceutical Market: Hungary - 2007 Update
The Pharmaceutical Market: Jordan - 2007 Update
The Pharmaceutical Market: Bangladesh
|
|
|
|
